SpiroSano

SpiroSano is the first end-to-end technology solution for managing respiratory disease states, such as asthma or COPD. A patent-pending, HIPPA-compliant framework, SpiroSano offers doctors and patients a truly flexible solution, which seamlessly combines devices, data sources and applications to create personalized “disease management kits.” The “patient kit” consists of a personalized set of monitoring parameters prescribed by a doctor, and matched with a set of appropriate devices and apps, such as spirometers, pulse oximeters, or activity trackers. With our Physician portal, doctors have the unprecedented opportunity to monitor their patients while they go about their day-to-day lives. This way, they can learn more about true triggers, patterns, and opportunities to manage the condition. Asthma and COPD impact more than 50 million people in the US alone and account for over $100 Billion in direct and indirect costs annually. The SpiroSano solution has the potential to significantly reduce the cost of managing these conditions by preventing exacerbations, eliminating unnecessary emergency room visits, and reducing the number of in person check-ups, while improving outcomes and increasing patient’s satisfaction. By integrating with connected devices, both medical and consumer, we have access to a rapidly expanding set of “always-on” biological parameters. With our open model, SpiroSano stands to become the technology platform of choice in the respiratory management space for patients, providers and payors.

网站

https://www.spirosano.com

SpiroSano的外部链接

所属行业

医院和医疗保健

规模

2-10 人

类型

私人持股

创立

2014